Drug Shortages Amid The Covid

Hydroxychloroquine is one generic drug that Novartis said it’ll assess in clinical trials. Novartis also strategies to sponsor or co-sponsor medical trials to study ruxolitinib and canakinumab for hospitalized patients with COVID-19 microbe infections. Ruxolitinib is promoted by Incyte in the U.S. as Jakafi® and by Novartis abroad as Jakavi®. The combo of hydroxychloroquine and… Continue reading Drug Shortages Amid The Covid

Published
Categorized as Uncategorized Tagged ,